Autoimmune Drugs Markets in China
Topics: Autoimmune, Country Overviews, Manufacturing, Packaging & Detailing
Regions: China
|
Chronic Plaque Psoriasis – Pipeline Review, H1 2013
Topics: Autoimmune, Drug Discovery
|
EpiCast Report: Psoriasis - Epidemiology Forecast to 2022
Topics: Autoimmune, Drug Discovery
|
Moderate Psoriasis – Pipeline Review, H1 2013
Topics: Autoimmune, Drug Discovery
|
Psoriasis – Pipeline Review, H1 2013
Topics: Autoimmune, Drug Discovery
|
Severe Psoriasis – Pipeline Review, H1 2013
Topics: Autoimmune, Drug Discovery
|
Systemic Lupus Erythematosus – Pipeline Review, H1 2013
Topics: Autoimmune, Drug Discovery
|
Autoimmune Disorders – Pipeline Review, H1 2013
Topics: Autoimmune, Drug Discovery
|
Psoriasis Partnering 2007-2013
Topics: Autoimmune, Drug Discovery
|
Systemic Lupus Erythematosus Partnering 2007-2013
Topics: Autoimmune, Drug Discovery
|
Global Immunoglobulin Products Market 2011-2015
Topics: Antibody Technologies, Autoimmune, Gerontology/Aging
Regions: Global
|
Acquired (Autoimmune) Hemolytic Anemia – Pipeline Review, H2 2012
Topics: Autoimmune, Drug Discovery
|
ChartTrends®: Lupus (US) 2012
Topics: Autoimmune, Research & Development, Clinical Trial
Regions: United States
|
U.S. Payer and Prescriber Attitudes Toward Novel Oral, Topical, and Biologic Emerging Agents in the Psoriasis Market: Implications for Market Access
Topics: Biologics, Autoimmune, Drug Discovery, Biopharmaceuticals
Regions: United States
|
TreatmentTrends®: Lupus (US) 2012
Topics: Autoimmune, Drug Discovery
Regions: United States
|
Chronic Plaque Psoriasis Global Clinical Trials Review, H2, 2012
Topics: Autoimmune, Clinical Trial
Regions: Global
|
Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012-2017) (Neurodegenerative, cardiovascular, cancer & autoimmune, skin and infectious diseases)
Topics: Research & Development, Stem Cell, Autoimmune, Cardiovascular, Infectious Diseases, Oncology/Hematology
|
Dermatology Therapeutics Market to 2018 - Novel Biologics Targeting Interleukin-17 Receptor Presents New Options in Psoriasis Treatment
Topics: Biologics, Autoimmune, Research & Development, Drug Discovery, Biopharmaceuticals, Dermatology
|
TreatmentTrends®: Lupus (EU) 2012
Topics: Autoimmune, Drug Discovery
|
Psoriasis
Topics: Autoimmune
|
Intravenous Immunoglobulin (IVIg)
Topics: Antibody Technologies, Autoimmune, Needles, Syringes, IV Access
Regions: Global
|
Fibromyalgia
Topics: Pain, Autoimmune, Drug Discovery, Women's Health
|
Psoriasis Pipeline Perspectives Report - Intracellular Signaling Blockers
Topics: Autoimmune, Drug Discovery
|
Psoriasis Pipeline Perspectives Report
Topics: Autoimmune, Drug Discovery
|
Psoriasis Pipeline Perspectives Report - Direct Inflammatory Cytokine Blockers
Topics: Autoimmune, Drug Discovery
|
Psoriasis Pipeline Perspectives Report - T-cell Activation Blockers
Topics: Autoimmune, Drug Discovery
|
Psoriasis Pipeline Perspectives Report - T-cell Migration Blockers
Topics: Autoimmune, Drug Discovery
|
Psoriasis Pipeline Perspectives Report - Inflammatory Cytokine Blockers
Topics: Autoimmune, Drug Discovery
|
PatientTrends®: Lupus 2012
Topics: Autoimmune, Drug Discovery
|
Psoriasis Market Info™
Topics: Autoimmune, Research & Development, Drug Discovery
|
Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments
Topics: Autoimmune, Multiple Sclerosis (MS), Research & Development
|
Psoriasis Global Clinical Trials Review, H1, 2012
Topics: Autoimmune, Drug Discovery, Clinical Trial
Regions: Global
|
Systemic Lupus Erythematosus
Topics: Autoimmune, Drug Discovery
|
Systemic Lupus Erythematosus: Which Clinical Attributes Will Most Effectively Position Emerging Biologics Against Belimumab in the Moderate to Severe Patient Segment?
Topics: Biologics, Autoimmune, Drug Discovery, Biopharmaceuticals
|
Innovative R&D and Dealmaking Opportunities: Immune and Inflammatory Disease Biologics
Topics: Research & Development, Biologics, Autoimmune, Biopharmaceuticals
|
Psoriasis (Moderate to Severe): Could an Emerging Therapy Obtain Commercial Success by Targeting Unmet Needs in Safety and Tolerability?
Topics: Autoimmune, Research & Development, Drug Discovery
|
Treatment Algorithms: Psoriasis – Prescribing trends mirror guidelines
Topics: Autoimmune, Drug Discovery
|
Endpoints - Clinical Trials in Autoimmune Disorders - Multiple Primary and Secondary Endpoints are Increasingly Being Applied to Ensure Success
Topics: Autoimmune, Clinical Trial
|
Liver Disease Treatments: The Global Market
Topics: Hepatitis, Autoimmune, Vaccines
Regions: Global
|
Celiac Disease - Pipeline Assessment and Market Forecasts to 2019
Topics: Autoimmune, Drug Discovery
|
Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market
Topics: Antibody Technologies, Autoimmune
|
Market and Product Forecasts: Psoriasis – Novel products and current biologics to fuel future market growth
Topics: Biologics, Autoimmune, Biopharmaceuticals
|
Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H2 2011
Topics: Autoimmune, Drug Discovery
|
Auto Inflammatory Disease - Pipeline Review, H2 2011
Topics: Autoimmune, Drug Discovery
|
Orphan Autoimmune Disorders to 2017 - Strong Performance by Nplate and Promacta and Future Launches of Immunoglobulin Therapies will Drive the ITP Market
Topics: Antibody Technologies, Autoimmune, Research & Development
|
Systemic Lupus Erythematosus Therapeutics (SLE) - Pipeline Assessment and Market Forecasts to 2018
Topics: Autoimmune, Drug Discovery
|
Neuromodulation Devices: World Market Prospects 2011-2021
Topics: Autoimmune, Medical Devices, Orthopedics
|
Drugs and Treatments for Autoimmune Diseases: Global Markets
Topics: Autoimmune
Regions: Global
|
Celiac Disease - Pipeline Review, H2 2011
Topics: Autoimmune, Drug Discovery
|
Immunoglobulins Market to 2017 - Off-Label Usage and Treatment of Primary Immunodeficiency Diseases and Neurological Disorders Stimulate Market Growth
Topics: Antibody Technologies, Autoimmune, Research & Development, Diseases & Conditions, Drug Discovery
|
